Dupuytren’s disease cords are weakened ex vivo by injection of recombinant collagenase G – A proof-of-concept study
Open Access
- 24 September 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0359330
Abstract
Objectives: Dupuytren’s disease is a fibroproliferative disorder that is characterized by collagen-rich cords that cause progressive flexion contractures. Collagenase from Clostridium histolyticum is an established nonsurgical therapy. Herein, we evaluated whether a recombinant form of collagenase G (ColG), expressed in Escherichia coli , weakens Dupuytren’s cords ex vivo. Methods: Cords from Dupuytren’s disease patients were excised during surgery. Using a 30G needle, 0.5 mL of 4 mg/ml ColG or phosphate buffer Saline (PBS) was injected into the cord center. Samples were incubated in saline at 37 °C and mounted via size-1 Prolene Krackow sutures on an Instron tensile testing system. Force vs. displacement curves were recorded. Results: Six cords from five patients were tested (ColG n = 4; PBS n = 2). Representative force–displacement curves showed a reduced slope and lower peak force prior to rupture in ColG-treated samples compared with vehicle. The mean maximum rupture force was lower with ColG than with PBS (0.047 kN vs 0.069 kN), corresponding to ~32% reduction in the force required to tear the cord in this series. Conclusions: Recombinant ColG weakens the tensile strength of Dupuytren’s cords ex vivo, consistent with potent collagenolytic activity. These proof-of-concept pilot data support further studies to define dose–response, optimize formulation and exposure time, and evaluate safety and clinical performance relative to current collagenase-based treatments.Keywords
This publication has 30 references indexed in Scilit:
- Epidemiologie des Morbus DupuytrenDer Orthopäde, 2017
- Adverse Effects of Collagenase in the Treatment of Dupuytren Disease: A Systematic ReviewBioDrugs, 2017
- Efficacy and Safety of Injectable Mixed Collagenase Subtypes in the Treatment of Dupuytren’s ContractureThe Journal of Hand Surgery, 2007
- The Complications of Dupuytren’s Contracture SurgeryThe Journal of Hand Surgery, 2005
- A Retrospective Review of the Management of Dupuytren’s NodulesThe Journal of Hand Surgery, 2005
- Collagenase in the treatment of Dupuytren's disease: An in vitro studyThe Journal of Hand Surgery, 1996
- Dupuytren’s Contracture: The Long-Term Results after Day SurgeryJournal of Hand Surgery (European Volume), 1991
- The cytoskeleton and extracellular matrix of the Dupuytren's disease “myofibroblast”: An immunofluorescence study of a nonmuscle cell typeThe Journal of Hand Surgery, 1986
- A Population Study of Dupuytren's ContractureHand, 1983
- Dupuytren's disease—A study of the pattern of distribution and stage of contracture in the handHand, 1976